Connect with us

Hi, what are you looking for?

News

Target’s Much-Needed Normalization May Be Over (NYSE:TGT)

The TGT Investment Thesis Remains Decent As A Long-Term Income Play

We previously covered Target (NYSE:TGT) in June 2023, discussing its oversold status then, attributed to the lowered FQ2’23 forward guidance and the $1.1B impact to FY2023’s gross profits from

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Follow Play Earnings CallPlay Earnings Call Disc Medicine, Inc. (IRON) Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs...

Videos

Watch full video on YouTube